Health and Healthcare
Medtronic Adjusts Long-Term Goals (MDT)
Published:
Last Updated:
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over and over how this notion has not been the case. Medtronic Inc. (NYSE: MDT) today highlighted further evidence that medical technology has to adjust to a new, harsher environment.
The company was presenting data at the J.P. Morgan health careconference and it brought down some of its longer-term forecasts. Itblamed a sluggish market for new implantable defibrillators, but theeconomy is the likely culprit here.
The company still expects earnings growth in the double-digits andit reaffirmed earnings targets for the fiscal April-2009 period.
Medtronic’s prior long-term sales growth over the next five years was 9% to 11%. The company now sees sales growing 5% to 8% for near-term, but put its long-term earningsgrowth target at 10% or more. Its prior growth target was roughly 11%to 14%.
This comes on the heels of its announcement that it plans to purchaseAblation Frontiers for an initial payment of $225 million pluspotential initial payments. With a $36 billion market cap, thatacquisition will hardly be noticed any time soon.
Jon C. Ogg
January 12, 2009
Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.
Here’s how it works:
1️ Answer a Few Simple Questions
Tell us a bit about your goals and preferences—it only takes a few minutes!
2️ Get Your Top Advisor Matches
This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.
3️ Choose Your Best Fit
Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.